Revolution Medicines, Inc. is 10.1x more valuable than Adaptive Biotechnologies Corp by market capitalization ($30.74 B vs $3.05 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADPT | RVMD |
|---|---|---|
| Market cap | $3.05 B | $30.74 B |
| US-listed rank | #1800 | #453 |
| Revenue (latest FY) | $276.98M | $0.00 |
| Net income (latest FY) | -$59.50M | -$1.13B |
| Net margin | -21.5% | - |
| SEC filings | 764 | 782 |
Revolution Medicines, Inc. is 10.1x more valuable than Adaptive Biotechnologies Corp by market capitalization ($30.74 B vs $3.05 B).
In their latest fiscal years, Adaptive Biotechnologies Corp reported $276.98M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Adaptive Biotechnologies Corp and Revolution Medicines, Inc., or browse the full rankings.